Profil
Jonathan D.
Alspaugh is President & Chief Strategy Officer at Rycarma Therapeutics, Inc. since 2024.
Formerly, Mr. Alspaugh was President, CEO, CFO & Chief Accounting Officer at Spyre Therapeutics, Inc. in 2023.
From 2013 to 2021, Mr. Alspaugh was Managing Director at Evercore, Inc. Education includes undergraduate and graduate degrees from the University of Michigan and an MBA from MIT Sloan School of Management.
Aktive Positionen von Jonathan Alspaugh
| Unternehmen | Position | Beginn |
|---|---|---|
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Präsident | 07.01.2024 |
Ehemalige bekannte Positionen von Jonathan Alspaugh
| Unternehmen | Position | Ende |
|---|---|---|
| EVERCORE INC. | Vorstandsvorsitzender | 01.06.2021 |
| SPYRE THERAPEUTICS, INC. | Vorstandsvorsitzender | - |
Ausbildung von Jonathan Alspaugh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Evercore, Inc.
Evercore, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















